• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORP. LIPOSORBER LA-15 SYSTEM; APHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORP. LIPOSORBER LA-15 SYSTEM; APHERESIS SYSTEM Back to Search Results
Model Number LA-15
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Dyspnea (1816); High Blood Pressure/ Hypertension (1908); Tachycardia (2095)
Event Date 01/25/2019
Event Type  Injury  
Event Description
A (b)(6) y.O boy with recurrent fsgs post-transplant.Has been receiving plasmapheresis up until today.Gfr well below 60 but a moot point in post-transplant; serum creatinine 2.9; serum protein 4.6; albumin 3.5; h&h 9.2, 28.6; 305 platelets.He was on ace-i (enalapril) and off for 72 hours according to his mother.He had a double lumen ij patent with good flows.Plasma volume tb treated 4,200 ml (90kg x 60ml).1.8 u heparin for bolus and 1.8 u heparin during treatment (25 u per kg).Two alarms early on for venous pressure which were quickly remedied with a flush.His mother states that one of the ports was not working well and the nurses doing the plasmapheresis only used one of the ports.Started at 60ml bfr and 20% pfr.Treatment started at 09:48 vss 125/76-84-16 skin warm, and dry color normal at 10:04, 16" into treatment, patient complained of chest pain and started thrashing in the bed; color pale lips cyanotic even though pulse ox 100%.The patient was lowered the head of the bed got o2 non rebreather mask; stopped the pumps had rn give 100 cc bolus normal saline (ns); code called and nurses gave solu medrol 125 and dr.Wanted 500 cc bolus ns given.Vs were 154/84-129-24.Patient within 5 minutes felt better.10:28 bp 128/78-72.Patient transferred to the er.Patient stable after 30 to 40".It was very first experience on him with liposorber switched from plasmaexchange (the last pex was (b)(6) 2020).Mfr# 3002808904-2019-00005.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIPOSORBER LA-15 SYSTEM
Type of Device
APHERESIS SYSTEM
Manufacturer (Section D)
KANEKA CORP.
2-3-18
nakanoshima, kita-ku
osaka-city, osaka 530-8 288,
JA  530-8288,
MDR Report Key11036533
MDR Text Key222628071
Report Number2435151-2020-00002
Device Sequence Number1
Product Code PBN
UDI-Device Identifier14993478010110
UDI-Public14993478010110
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 01/28/2019,12/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberLA-15
Device Catalogue NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date01/25/2019
Event Location Hospital
Date Report to Manufacturer01/28/2019
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age15 YR
-
-